Defining Trajectories of Response in Psoriasis Patients Treated with Biologic Therapies
Br J Dermatol, 2021.
Geifman N, Azadbakht N, Zeng J, Wilkinson T, Dand N, Buchan I, Stocken D, Di Meglio P, Warren RB, Barker JN; Reynolds NJ, Barnes MR, Smith CH, Griffiths CEM, Peek N; BADBIR Study Group, on behalf of the PSORT Consortium.
Read publication: Br J Dermatol 2021
Related
Characteristics of "super responders" and "super nonresponders" to first biologic monotherapy for ps...
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoria...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
0 Comments